Skip to content

Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession

Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession: a Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06621433
Enrollment
44
Registered
2024-10-01
Start date
2023-01-01
Completion date
2024-01-22
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Brief summary

The aim of the study is to evaluate the effectiveness of using titanium prepared platelet rich fibrin with coronally advanced flap in the treatment of type-2 Cairo gingival recession.

Interventions

OTHERT-PRF with CAF

Blood sample will be obtained from the patient, conveyed into a titanium tube and immediately centrifuged at 2700 rpm for 12 mins at room temperature using fixed angle centrifuge (PRF Process, Tangkula800-1, China). The fibrin clot will be collected and placed in the PRF compression device (PRF GRF box) and condensed to produce a uniform T-PRF membrane which will be inserted over the recession area and covered by the coronally advanced flap.

OTHERSECTG with CAF

Sub epithelial connective tissue graft will be obtained from the donor site (hard palate), placed into recipient site and secured by sutures, then covered by a coronally advanced flap.

Sponsors

Rizk Beshir
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Gingival recession type 2 according to Cairo et al (2011). * Adequate amount of Attached Gingiva (AG) (2 mm≤ AG). * Good oral hygiene (full mouth bleeding score and O'Leary index less than ≤10 % after complete phase I therapy) * Clinically thick gingival biotype (1mm < gingival thickness). * Anterior esthetic zone.

Exclusion criteria

* Patients with gingival recession types 1 and 3 according to Cairo et al. * Inadequate amount of attached gingiva (AG < 2 mm). * Uncooperative patients. * Smoking more than 10 cigarettes per day. * Patients with known systemic conditions or taking medications that may affect soft tissue healing. * Pregnant and lactating women. * Patients with parafunctional habits.

Design outcomes

Primary

MeasureTime frameDescription
Probing depthup to 6 monthsThe distance from the base of the pocket to the most apical point on the gingival margin will be measured using a periodontal probe.
Clinical attachment lossup to 6 monthsDistance from the cement-enamel junction to the base of the periodontal pocket will be measured using a periodontal probe
Recession width (RW)up to 6 monthsRecession width (W) measured at the widest point (it is the distance between the mesial gingival margin and the distal gingival margin of the tooth) using a periodontal probe
Recession height (RH)up to 6 monthsIt will be measured from the cementoenamel junction to the Gingival Margin (GM), parallel to the long axis of the tooth starting from the most apical point of the recession using a William's graduated periodontal probe
Width of keratinized gingiva (KT)up to 6 monthsWidth of keratinized gingiva will be measured as the distance from the gingival margin to the mucogingival junction

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026